Basics RAPT Therapeutics, Inc. IPO Date: October 28, 2019 Sector: Healthcare Industry: Biotech Market Cap: $175.45M Activated in VL: True Average Daily Range Avg Daily Range: $0.71 | 3.99% Avg Daily Range (30 D): $0.38 | 4.58% Avg Daily Range (90 D): $0.17 | 5.39% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 96 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 185 Institutional Trades Total Inst.Trades: 1,056 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $3.2M Avg Inst. Trade (90 D): $1.83M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.59M Avg Closing Trade (30 D): $3.2M Avg Closing Trade (90 D): $1.83M Avg Closing Volume: 10.97K     News Jun 23, 2025 @ 12:00 PM RAPT Therapeutics Names Two Industry Veterans to i... Source: Rapt Therapeutics, Inc. Jan 6, 2025 @ 1:00 PM RAPT Therapeutics Names Lori Lyons-Williams Cha... Source: Rapt Therapeutics, Inc. Jul 19, 2024 @ 2:00 PM Agenus (AGEN) Tanks on Colorectal Cancer Study Int... Source: N/A Jul 17, 2024 @ 2:01 PM Arcutis (ARQT) Stock Rises 31% in the Past Month: ... Source: Zacks Equity Research Jul 16, 2024 @ 2:30 PM Lisata (LSTA) Stock Rallies More Than 30% YTD: Her... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.08 $-1.22 $-3.19 Diluted EPS $-.08 $-1.22 $-3.19 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -17.17M $ -53.25M $ -129.87M Operating Income / Loss $ -19.27M $ -54.47M $ -136.1M Cost of Revenue $ $ $ Net Cash Flow $ M $ 131.84M $ 122.26M PE Ratio     Splits Jun 17, 2025:   1:8